Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

(2019) Hertzel C Gerstein et al.   LANCET

Inactivation of the Glucose-Dependent Insulinotropic Polypeptide Receptor Improves Outcomes following Experimental Myocardial Infarction

(2018) John R. Ussher et al.   Cell Metabolism

The MR-Base platform supports systematic causal inference across the human phenome

(2018) Gibran Hemani et al.   eLife

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

(2018) Adrian F Hernandez et al.   LANCET

Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants

(2017) Stephen Burgess et al.   EPIDEMIOLOGY

MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data

(2017) Olena O Yavorska et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Pro-inflammatory gene expression profile in obese adults with high plasma GIP levels

(2017) J Góralska et al.   INTERNATIONAL JOURNAL OF OBESITY

Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease

(2017) Pim van der Harst et al.   CIRCULATION RESEARCH

Suppressive Effects of Glucose-Dependent Insulinotropic Polypeptide on Cardiac Hypertrophy and Fibrosis in Angiotensin II-Infused Mouse Models

(2016) Munenori Hiromura et al.   CIRCULATION JOURNAL

Vascular Biology of Glucagon Receptor Superfamily Peptides: Mechanistic and Clinical Relevance

(2016) Gemma Pujadas et al.   ENDOCRINE REVIEWS

Glucose-Dependent Insulinotropic Polypeptide Is Associated With Lower Low-Density Lipoprotein But Unhealthy Fat Distribution, Independent of Insulin: The ADDITION-PRO Study

(2016) Cathrine Laustrup Møller et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Atrial Natriuretic Peptide in the High Normal Range Is Associated With Lower Prevalence of Insulin Resistance

(2016) Amra Jujić et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

(2016) Steven P. Marso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

(2016) Steven P. Marso et al.   NEW ENGLAND JOURNAL OF MEDICINE

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

(2016) Robert A. Scott et al.   Science Translational Medicine

Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: The Malmö Diet and Cancer Study

(2015) M. Rosvall et al.   ATHEROSCLEROSIS

Glucose-Dependent Insulinotropic Polypeptide (GIP) Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB

(2015) Lisa M. Berglund et al.   DIABETES

Conducting Meta-Analyses inRwith themetaforPackage

(2015) Wolfgang Viechtbauer   Journal of Statistical Software

Osteopontin – A multi-modal marker and mediator in atherosclerotic vascular disease

(2014) Talya Wolak   ATHEROSCLEROSIS

Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial

(2013) Steven P. Marso et al.   AMERICAN HEART JOURNAL

Link Between GIP and Osteopontin in Adipose Tissue and Insulin Resistance

(2013) E. Ahlqvist et al.   DIABETES

Pleiotropic Effects of GIP on Islet Function Involve Osteopontin

(2011) V. Lyssenko et al.   DIABETES

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

(2011) Heribert Schunkert et al.   NATURE GENETICS

A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)–Botnia study

(2010) B. Isomaa et al.   DIABETOLOGIA

Adaptive selection of an incretin gene in Eurasian populations

(2010) C. L. Chang et al.   GENOME RESEARCH

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge

(2010) Richa Saxena et al.   NATURE GENETICS